Center for Clinical Studies | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Active, not recruiting	Phase 2	2026-09-25		NCT07230860
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata	Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder	Recruiting	Phase 3	2026-09-18		NCT06873945
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, nutritional disorder, obesity disorder, overnutrition, psoriasis, skin disorder	Recruiting	Phase 4	2026-09-04		NCT06857942
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)	NonSegmental Vitiligo	Active, not recruiting	Phase 3	2026-08-25		NCT06113445
A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2	Active Nonsegmental Vitiligo; Stable Nonsegmental Vitiligo	Active, not recruiting	Phase 3	2026-06-24		NCT06072183
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients	Non-segmental Vitiligo	Recruiting	Phase 2	2026-06-05		NCT07223229